The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 20 Jul 2004
doi: 10.1242/jcs.01249
Research Article
Nucleolar localization of the human telomeric repeat binding factor 2 (TRF2)
Suisheng Zhang,
Peter Hemmerich,
and
Frank Grosse*
* Author for correspondence (e-mail: fgrosse{at}imb-jena.de)
The telomeric repeat binding factor 2 (TRF2) specifically recognizes TTAGGG tandem repeats at chromosomal ends. Unexpectedly immunofluorescence studies revealed a prominent nucleolar localization of TRF2 in human cells, which appeared as discrete dots with sizes similar to those present in the nucleoplasm. The TRF2 dots did not overlap with dots stemming from the upstream binding factor (UBF) or the B23 protein. After treatment with a low concentration of actinomycin D (0.05 µg/ml), TRF2 remained in the nucleolus, although this condition selectively inhibited RNA polymerase I and led to a relocalization of UBF and B23. TRF2 was prominent in the nucleolus at G0 and S but seemed to diffuse out of the nucleolus in G2 phase. During mitosis TRF2 dispersed from the condensed chromosomes and returned to the nucleolus at cytokinesis. Treatment with low doses of actinomycin D delayed the release of TRF2 from the nucleolus as cells progressed from G2 phase into mitosis. With actinomycin D present TRF2 was detected in discrete foci adjacent to UBF in prophase, while in metaphase a complete overlap between TRF2 and UBF was observed. TRF2 was present in DNase-insensitive complexes of nucleolar extracts, whereas DNA degradation disrupted the protein-DNA complexes consisting of Ku antigen and B23. Following treatment with actinomycin D some of the mitotic cells displayed chromosome end-to-end fusions. This could be correlated to the actinomycin D-suppressed relocalization of TRF2 from the nucleolus to the telomeres during mitosis. These results support the view that the nucleolus may sequester TRF2 and thereby influences its telomeric functions.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Dejmek, J. D. Iglehart, and J.-B. Lazaro
DNA-Dependent Protein Kinase (DNA-PK)-Dependent Cisplatin-Induced Loss of Nucleolar Facilitator of Chromatin Transcription (FACT) and Regulation of Cisplatin Sensitivity by DNA-PK and FACT
Mol. Cancer Res.,
April 1, 2009;
7(4):
581 - 591.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Lee, T. L. Xuan Nguyen, J. W. Choi, K.-H. Lee, S.-W. Cho, Z. Liu, K. Ye, S. S. Bae, and J.-Y. Ahn
Nuclear Akt interacts with B23/NPM and protects it from proteolytic cleavage, enhancing cell survival
PNAS,
October 28, 2008;
105(43):
16584 - 16589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Wong, K. H. Brettingham-Moore, L. Chan, J. M. Quach, M. A. Anderson, E. L. Northrop, R. Hannan, R. Saffery, M. L. Shaw, E. Williams, et al.
Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere
Genome Res.,
August 1, 2007;
17(8):
1146 - 1160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Torrano, J. Navascues, F. Docquier, R. Zhang, L. J. Burke, I. Chernukhin, D. Farrar, J. Leon, M. T. Berciano, R. Renkawitz, et al.
Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism
J. Cell Sci.,
May 1, 2006;
119(9):
1746 - 1759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. R. Politz, I. Polena, I. Trask, D. P. Bazett-Jones, and T. Pederson
A Nonribosomal Landscape in the Nucleolus Revealed by the Stem Cell Protein Nucleostemin
Mol. Biol. Cell,
July 1, 2005;
16(7):
3401 - 3410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. W. Lam, L. Trinkle-Mulcahy, and A. I. Lamond
The nucleolus
J. Cell Sci.,
April 1, 2005;
118(7):
1335 - 1337.
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2004
